Skip to main content
Equibles

ASSETMARK, INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1344551 CONCORD, CA
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$13,645,122
+$2,876,666 QoQ
Shares Held
174,334
+4.6% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#101
of 667 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ASSETMARK, INC holds $347,870,603 across 93 Biotechnology names. HALO ranks #4 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 3,433,824 $186,834,363
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 61,055 $30,327,850
3 DFTX
Definium Therapeutics, Inc.
 396,542 $18,653,335
4 HALO
Halozyme Therapeutics, Inc.
This page 		174,334 $13,645,122
5 PTGX
Protagonist Therapeutics, Inc
 98,687 $12,097,052
6 ONC
BeOne Medicines Ltd.
 32,399 $9,232,743
7 REGN
Regeneron Pharmaceuticals, Inc.
 12,594 $7,852,862
8 ARGX
Argenx SE
 7,699 $7,142,901

All Filings in HALO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,645,122 174,334
2026-03-31 $10,768,456 166,617
2025-12-31 $9,248,029 137,415
2025-09-30 $9,009,598 122,847
2025-06-30 $6,322,406 121,538
2025-03-31 $6,762,009 105,971
2024-12-31 $4,913,481 102,771
2024-09-30 $5,332,421 93,159
2024-06-30 $4,438,766 84,774
2024-03-31 $4,391,324 107,948
2023-12-31 $3,887,896 105,192
2023-09-30 $2,348,765 61,486
2023-06-30 $2,811,836 77,955
2023-03-31 $1,439,457 37,692
2022-12-31 $1,668,649 29,326
2022-09-30 $1,006,293 25,450
2022-06-30 $95,920 2,180
2022-03-31 $53,638 1,345
2021-12-31 $56,535 1,406
2021-09-30 $55,121 1,355
2021-06-30 $56,081 1,235
2021-03-31 $51,487 1,235
2020-12-31 $39,720 930